- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05430568
Comparison of Post-operation Cardiopulmonary Capacity of Patients Underwent Conventional and Robot-assisted Coronary Artery Bypass Graft and Valve Replacement Surgery
Study Overview
Status
Intervention / Treatment
Detailed Description
The study is a prospective cohort study. The experimental group will include 40 patients, consisting 20 after robotic coronary artery bypass grafting and 20 after robotic valvuloplasty. The control group will include 20 patients for each conventional procedure.
Once decided the surgery type, the surgeon will consult the rehabilitation department and the director of this trial for inform consent. The recruitment and allocation will only be done after the patient has decided which type of surgery to receive. However, in case of change of surgery type, the patient will be excluded from the trial.
Cardiopulmonary exercise testing, 6-minute walking test and questionnaires about wound pain and cardiac functional status will be performed before surgery, two weeks after discharge and three months after discharge respectively. Primary outcomes include the change of maximal oxygen consumption (VO2), anaerobic threshold and the result of six minute walking test before and after surgery. Secondary outcomes include the change vital capacity (FVC), resting heart rate, oxygen pulse (O2 pulse), wound pain visual analog scale (VAS) and Duke Activity Status Index (DASI) before and after surgery.
The hypothesis of this study is that patients who undergo robot-assisted surgery will have better cardiopulmonary outcomes than those receive conventional surgery
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Yuchun Lee, MD
- Phone Number: 3207 886-4-23592525
- Email: lyczoj@vghtc.gov.tw
Study Locations
-
-
Taiwan
-
Taichung, Taiwan, Taiwan, 40705
- Department of Physical Medicine and Rehabilitation
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- patient who undergo surgery for coronary artery bypass graft or valvular replacement.
Exclusion Criteria:
- pregnant
- patients who receive more than one type of surgery
- severe complications after surgery (ex. respiratory failure, stroke) and stayed in hospital for more than 2 weeks.
- cannot perform the cardiopulmonary exercise testing
- other contraindications for cardiopulmonary exercise testing
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
bypass graft, sternotomy
patients who have received coronary artery bypass graft surgery with conventional sternotomy procedure
|
|
|
bypass graft, robot
patients who have received coronary artery bypass graft surgery with robot-assisted procedure
|
Other Names:
|
|
valvular heart disease, sternotomy
patients who have received valvular replacement surgery with conventional sternotomy procedure
|
|
|
valvular heart disease, robot
patients who have received valvular replacement surgery with robot-assisted procedure
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of maximal oxygen consumption post-surgery
Time Frame: pre-operation to 2 weeks post-operation
|
the change of maximal oxygen consumption from surgery before to 2 weeks after surgery
|
pre-operation to 2 weeks post-operation
|
|
Change of maximal oxygen consumption in 3 months
Time Frame: pre-operation to 3 months post-operation
|
the change of maximal oxygen consumption from before surgery to 3 months after surgery
|
pre-operation to 3 months post-operation
|
|
Change of anaerobic threshold post surgery
Time Frame: pre-operation to 2 weeks post-operation
|
the change of the onset of lactate accumulation in blood from before surgery to 2 weeks after surgery
|
pre-operation to 2 weeks post-operation
|
|
Change of anaerobic threshold in 3 months
Time Frame: pre-operation to 3 months post-operation
|
the change of the onset of lactate accumulation in blood from before surgery to 3 months after surgery
|
pre-operation to 3 months post-operation
|
|
Change of six minute walking test result post-surgery
Time Frame: pre-operation to 2 weeks post-operation
|
the change of six minute walking test result from before surgery to 2 weeks after surgery
|
pre-operation to 2 weeks post-operation
|
|
Change of six minute walking test result in 3 months
Time Frame: pre-operation to 3 months post-operation
|
the change of six minute walking test result from before surgery to 3 months after surgery
|
pre-operation to 3 months post-operation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of vital capacity post-surgery
Time Frame: pre-operation to 2 weeks post-operation
|
the change of vital capacity during pulmonary function testing from before surgery to 2 weeks after surgery
|
pre-operation to 2 weeks post-operation
|
|
Change of vital capacity in 3 months
Time Frame: pre-operation to 3 months post-operation
|
the change of vital capacity during pulmonary function testing from before surgery to 3 months after surgery
|
pre-operation to 3 months post-operation
|
|
Change of respiratory flow post-surgery
Time Frame: pre-operation to 2 weeks post-operation
|
the change of the ratio of air volume on exhalation to vital capacity during the first second in the pulmonary function testing from before surgery to 2 weeks after surgery
|
pre-operation to 2 weeks post-operation
|
|
Change of respiratory flow ratio in 3 months
Time Frame: pre-operation to 3 months post-operation
|
the change of the ratio of air volume on exhalation to vital capacity during the first second in the pulmonary function testing from before surgery to 3 months after surgery
|
pre-operation to 3 months post-operation
|
|
Change of resting heart rate post-surgery
Time Frame: pre-operation to 2 weeks post-operation
|
the change of resting heart rate from before surgery to 2 weeks after surgery
|
pre-operation to 2 weeks post-operation
|
|
Change of resting heart rate in 3 months
Time Frame: pre-operation to 3 months post-operation
|
the change of resting heart rate from before surgery to 3 months after surgery
|
pre-operation to 3 months post-operation
|
|
Change of oxygen pulse post-surgery
Time Frame: pre-operation to 2 weeks post-operation
|
the change of the maximal value of VO2 divided by heart rate during exercise testing from before surgery to 2 weeks after surgery
|
pre-operation to 2 weeks post-operation
|
|
Change of oxygen pulse in 3 months
Time Frame: pre-operation to 3 months post-operation
|
the change of the maximal value of VO2 divided by heart rate during exercise testing from before surgery to 3 months after surgery
|
pre-operation to 3 months post-operation
|
|
pain post-surgery
Time Frame: 2 weeks post-operation
|
pain visual analog scale score (from 0 to 10, higher score means more painful) for surgery wound pain at 2 weeks after surgery
|
2 weeks post-operation
|
|
pain in 3 months
Time Frame: 3 months post-operation
|
pain visual analog scale score (from 0 to 10, higher score means more painful) for surgery wound pain at 3 months after surgery
|
3 months post-operation
|
|
Change of activity status post-surgery
Time Frame: pre-operation to 2 weeks post-operation
|
the change of the Duke Activity Status Index (DASI) score from before surgery to 2 weeks after surgery. The DASI is a score ranging from 0 to 58.2. A higher score indicates a better cardiorespiratory fitness. |
pre-operation to 2 weeks post-operation
|
|
Change of activity status in 3 months
Time Frame: pre-operation to 3 months post-operation
|
the change of the Duke Activity Status Index (DASI) score from before surgery to 3 months after surgery The DASI is a score ranging from 0 to 58.2.
A higher score indicates a better cardiorespiratory fitness.
|
pre-operation to 3 months post-operation
|
Collaborators and Investigators
Investigators
- Study Director: Yuchun Lee, MD, Taichung Veterans General Hospital
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CE22214A
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Valvular Heart Disease
-
Dacima ConsultingTunisian Society of Cardiology and Cardiovascular SurgeryCompletedValvular Heart Disease | Valvular Stenosis | Valvular InsufficiencyTunisia
-
Yonsei UniversityCompletedMitral Valvular Heart Disease
-
National Defense Medical Center, TaiwanRecruiting
-
Shanghai Zhongshan HospitalCompletedElectrocardiogram, Valvular Heart DiseaseChina, United Kingdom
-
University of PennsylvaniaCompleted
-
Assiut UniversityCompleted
-
Assiut UniversityRecruitingValvular Heart Disease Stenosis and RegurgitationEgypt
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingValvular Heart Disease | Valvular Heart Disease Stenosis and RegurgitationRussian Federation
-
Ruijin HospitalMed-X Research Institute, Shanghai Jiao Tong UniversityActive, not recruitingPrimary Valvular Heart Disease With Comorbid Coronary Artery Disease | Planned to Undergo Elective On-pump Valve Surgery Due to Primary Mitral and/or Aortic Valvular Heart DiseaseChina
-
Assiut UniversityActive, not recruitingValvular Heart Disease Stenosis and RegurgitationEgypt
Clinical Trials on robot-assisted surgery
-
Institut Paoli-CalmettesNot yet recruiting
-
Changhai HospitalUnknownNephrectomy | Robotic Surgical Procedures | ProstatectomyChina
-
The Affiliated Hospital of Qingdao UniversityRecruitingProstate Cancer | Bladder Cancer | Renal CancerChina
-
Cornerstone RoboticsActive, not recruitingCervical Cancer | Endometrial CancerChina
-
University of OxfordCompletedEpiretinal Membrane | Retinal HemorrhageUnited Kingdom
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingGynecologic Cancer | Endometrial Neoplasms | Obesity, Morbid | Endometrial Cancer | Gynecologic DiseaseItaly
-
Instituto do Cancer do Estado de São PauloUnknownHead and Neck Cancer | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Renal Cancer | Uterus CancerBrazil
-
Kyungpook National University HospitalUnknownRectal CancerKorea, Republic of
-
Southwest Hospital, ChinaRecruiting
-
Société Française d'Anesthésie et de RéanimationCompletedRobot-assisted Urological SurgerySpain, France, Belgium